Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Betts

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|March 6, 2022
Predictors and outcomes of flares in chronic graft-versus-host diseaseNajla El Jurdi, Grigori Okoev, Todd E DeFor, et al.
Haematologica|September 14, 2023
Amphiregulin as a biomarker for monitoring lifethreatening acute graft-<i>versus</i>-host disease: secondary analysis of two prospective clinical trialsShernan G Holtan, Najla El Jurdi, Armin Rashidi, et al.
British Journal of Haematology|August 9, 2023
Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host diseaseNajla El Jurdi, Shernan G Holtan, Andrea Hoeschen, et al.
Clinical Transplantation|November 8, 2024
Novel Scoring System for Ranking Hematopoietic Stem Cell TransplantationLee Ann Baxter-Lowe, Tao Wang, Michelle Kuxhausen, et al.
Science Translational Medicine|January 13, 2017
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL functionBrian C Betts, Anandharaman Veerapathran, Joseph Pidala, et al.
Cancer Immunology Research|December 8, 2016
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 BlockadeShane A Curran, Justin A Shyer, Erin T St Angelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2020
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host DiseaseChiara Frairia, Maura Nicolosi, Jamie Shapiro, et al.
Transplantation and Cellular Therapy|November 14, 2021
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesTimothy D Gauntner, Claudio G Brunstein, Qing Cao, et al.
British Journal of Haematology|January 19, 2018
Hypoalbuminaemia segregates different prognostic subgroups within the refined standard risk acute graft-versus-host disease scoreMohamed A Kharfan-Dabaja, Kyle Sheets, Ambuj Kumar, et al.
Molecular Therapy Oncolytics|December 11, 2023
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemiaJustin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|March 6, 2022
Predictors and outcomes of flares in chronic graft-versus-host diseaseNajla El Jurdi, Grigori Okoev, Todd E DeFor, et al.
Haematologica|September 14, 2023
Amphiregulin as a biomarker for monitoring lifethreatening acute graft-<i>versus</i>-host disease: secondary analysis of two prospective clinical trialsShernan G Holtan, Najla El Jurdi, Armin Rashidi, et al.
British Journal of Haematology|August 9, 2023
Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host diseaseNajla El Jurdi, Shernan G Holtan, Andrea Hoeschen, et al.
Clinical Transplantation|November 8, 2024
Novel Scoring System for Ranking Hematopoietic Stem Cell TransplantationLee Ann Baxter-Lowe, Tao Wang, Michelle Kuxhausen, et al.
Science Translational Medicine|January 13, 2017
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL functionBrian C Betts, Anandharaman Veerapathran, Joseph Pidala, et al.
Cancer Immunology Research|December 8, 2016
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 BlockadeShane A Curran, Justin A Shyer, Erin T St Angelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2020
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host DiseaseChiara Frairia, Maura Nicolosi, Jamie Shapiro, et al.
Transplantation and Cellular Therapy|November 14, 2021
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic MalignanciesTimothy D Gauntner, Claudio G Brunstein, Qing Cao, et al.
British Journal of Haematology|January 19, 2018
Hypoalbuminaemia segregates different prognostic subgroups within the refined standard risk acute graft-versus-host disease scoreMohamed A Kharfan-Dabaja, Kyle Sheets, Ambuj Kumar, et al.
Molecular Therapy Oncolytics|December 11, 2023
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemiaJustin C Boucher, Bishwas Shrestha, Paresh Vishwasrao, et al.
Pageof 6